Literature DB >> 9765431

Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector.

L G Johnson1, J P Mewshaw, H Ni, T Friedmann, R C Boucher, J C Olsen.   

Abstract

To study retroviral gene transfer to airway epithelia, we used a transient transfection technique to generate high titers (approximately 10(9) infectious units/ml after concentration) of murine leukemia virus (MuLV)-derived vectors pseudotyped with the vesicular stomatitis virus envelope glycoprotein (VSV-G). Transformed (CFT1) and primary airway epithelial cells were efficiently transduced by a VSV-G-pseudotyped lacZ vector (HIT-LZ) in vitro. CFT1 cells and primary cystic fibrosis (CF) airway cell monolayers infected with a vector (HIT-LCFSN) containing human CF transmembrane conductance regulator (CFTR) in the absence of selection expressed CFTR, as assessed by Western blot analysis, and exhibited functional correction of CFTR-mediated Cl- secretion. In vitro studies of persistence suggested that pseudotransduction was not a significant problem with our vector preparations. In a sulfur dioxide (SO2) inhalational injury model, bromodeoxyuridine (BrdU) incorporation rates were measured and found to exceed 50% in SO2-injured murine tracheal epithelium. HIT-LZ vector (multiplicity of infection of approximately 10) instilled into the SO2-injured tracheas of anesthetized mice transduced 6.1% +/- 1.3% of superficial airway cells in tracheas of weanling mice (3 to 4 weeks old; n = 10), compared to 1.4 +/- 0.9% in mice 5 weeks of age (n = 4) and 0.2% in mice older than 6 weeks (n = 15). No evidence for gene transfer following delivery of HIT-LZ to tracheas of either weanling or older mice not injured with SO2 was detected. Because only a small fraction of BrdU-labeled airway cells were transduced, we examined the stability of the vector. No significant loss of vector infectivity over intervals (2 h) paralleling those of in vivo protocols was detected in in vitro assays using CFT1 cells. In summary, high-titer vectors permitted complementation of defective CFTR-mediated Cl- transport in CF airway cells in vitro without selection and demonstrated that the age of the animal appeared to be a major factor affecting in vivo retroviral transduction efficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765431      PMCID: PMC110303     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Ozone-induced acute tracheobronchial epithelial injury: relationship to granulocyte emigration in the lung.

Authors:  D M Hyde; W C Hubbard; V Wong; R Wu; K Pinkerton; C G Plopper
Journal:  Am J Respir Cell Mol Biol       Date:  1992-05       Impact factor: 6.914

2.  Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions.

Authors:  M A Adam; N Ramesh; A D Miller; W R Osborne
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Reconstitution of tracheal grafts with a genetically modified epithelium.

Authors:  J F Engelhardt; E D Allen; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells.

Authors:  C J Venglarik; R J Bridges; R A Frizzell
Journal:  Am J Physiol       Date:  1990-08

5.  Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis.

Authors:  L L Clarke; B R Grubb; S E Gabriel; O Smithies; B H Koller; R C Boucher
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

6.  Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein.

Authors:  Y Yang; E F Vanin; M A Whitt; M Fornerod; R Zwart; R D Schneiderman; G Grosveld; A W Nienhuis
Journal:  Hum Gene Ther       Date:  1995-09       Impact factor: 5.695

7.  Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells.

Authors:  B Sarkadi; D Bauzon; W R Huckle; H S Earp; A Berry; H Suchindran; E M Price; J C Olson; R C Boucher; G A Scarborough
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

8.  In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

Authors:  M A Rosenfeld; K Yoshimura; B C Trapnell; K Yoneyama; E R Rosenthal; W Dalemans; M Fukayama; J Bargon; L E Stier; L Stratford-Perricaudet
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

9.  Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer.

Authors:  J C Olsen; L G Johnson; M J Stutts; B Sarkadi; J R Yankaskas; R Swanstrom; R C Boucher
Journal:  Hum Gene Ther       Date:  1992-06       Impact factor: 5.695

10.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.

Authors:  A D Miller; J V Garcia; N von Suhr; C M Lynch; C Wilson; M V Eiden
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more
  19 in total

Review 1.  Status of gene therapy for cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes.

Authors:  Xiangli Li; Sergei S Makarov
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

3.  p53-Dependent but ATM-independent inhibition of DNA synthesis and G2 arrest in cadmium-treated human fibroblasts.

Authors:  Feng Cao; Tong Zhou; Dennis Simpson; Yingchun Zhou; Jayne Boyer; Bo Chen; Taiyi Jin; Marila Cordeiro-Stone; William Kaufmann
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-11       Impact factor: 4.219

4.  Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism.

Authors:  C Norez; C Vandebrouck; J Bertrand; S Noel; E Durieu; N Oumata; H Galons; F Antigny; A Chatelier; P Bois; L Meijer; F Becq
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

5.  Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect.

Authors:  G Wang; V Slepushkin; J Zabner; S Keshavjee; J C Johnston; S L Sauter; D J Jolly; T W Dubensky; B L Davidson; P B McCray
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding.

Authors:  Simon N Waddington; Rachel Crossley; Vicky Sheard; Steven J Howe; Suzanne M K Buckley; Lynda Coughlan; David E Gilham; Robert E Hawkins; Tristan R McKay
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

7.  Integrin alphaIIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells.

Authors:  D A Wilcox; J C Olsen; L Ishizawa; M Griffith; G C White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

8.  Endoplasmic reticulum/golgi nucleotide sugar transporters contribute to the cellular release of UDP-sugar signaling molecules.

Authors:  Juliana I Sesma; Charles R Esther; Silvia M Kreda; Lisa Jones; Wanda O'Neal; Shoko Nishihara; Robert A Nicholas; Eduardo R Lazarowski
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

9.  High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.

Authors:  Manij Patel; Angela M Giddings; John Sechelski; John C Olsen
Journal:  J Gene Med       Date:  2013-01       Impact factor: 4.565

10.  Lentivirus vector can be readministered to nasal epithelia without blocking immune responses.

Authors:  Patrick L Sinn; Ariadna C Arias; Kim A Brogden; Paul B McCray
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.